Pds Biotechnology Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.72

+0.02 (+3.59%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,730.8% upside

Low Target $11.64

Average Target $20.24

High Target $22.20

Current Price $0.72

Current
$0.72

Target
$20.24

$11.64 $20.24 avg $22.20

Scenario Analysis

Bear Case

$11.64

1,528.0%

Low target

Base Case

$20.24

+2,730.8%

Avg target

Bull Case

$22.20

+3,004.9%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$20.82

-96.6% from high

52-Week Low

$13.78

+-94.8% from low

Target vs 52W High

$20.24

-2.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%